T1	chemical 5 11	sodium
T3	disease_or_phenotypic_feature 67 80	heart failure
T4	disease_or_phenotypic_feature 97 104	obesity
T5	disease_or_phenotypic_feature 106 127	Prader-Willi syndrome
T6	disease_or_phenotypic_feature 177 191	hypothyroidism
T8	disease_or_phenotypic_feature 224 253	hypogonadotropic hypogonadism
T9	chemical 265 285	proteasome inhibitor
T10	chemical 304 314	bortezomib
T11	disease_or_phenotypic_feature 344 360	multiple myeloma
T12	chemical 389 399	biomarkers
T13	disease_or_phenotypic_feature 404 417	heart failure
T14	chemical 443 451	Gartanin
T15	chemical 570 576	enzyme
T16	corrected_chemical 578 581	NAE
T17	disease_or_phenotypic_feature 701 716	prostate cancer
T18	chemical 789 799	Duloxetine
T19	chemical 826 840	antidepressant
T20	chemical 841 845	drug
T21	disease_or_phenotypic_feature 905 913	diabetic
T22	disease_or_phenotypic_feature 914 935	peripheral neuropathy
T23	chemical 970 984	Growth hormone
T24	disease_or_phenotypic_feature 1023 1030	obesity
T25	chemical 1114 1123	magnesium
T27	chemical 1149 1158	Magnesium
T28	disease_or_phenotypic_feature 1227 1240	hypercalcemia
T29	disease_or_phenotypic_feature 1245 1261	hypophosphatemia
T30	disease_or_phenotypic_feature 1317 1325	melanoma
T31	chemical 1339 1346	antigen
T32	chemical 1356 1362	MART-1
T33	disease_or_phenotypic_feature 1387 1395	melanoma
T34	chemical 1473 1487	growth hormone
T35	disease_or_phenotypic_feature 1491 1509	skeletal dysplasia
T36	chemical 1527 1539	misonidazole
T37	disease_or_phenotypic_feature 1554 1565	gliosarcoma
T38	chemical 1605 1611	oxygen
T40	chemical 1692 1695	MCC
T42	chemical 1731 1734	MCC
T43	disease_or_phenotypic_feature 1771 1784	herpes zoster
T45	disease_or_phenotypic_feature 1797 1819	retinal vein occlusion
T46	disease_or_phenotypic_feature 1891 1910	active tuberculosis
T47	chemical 1985 1997	Testosterone
T48	disease_or_phenotypic_feature 2026 2041	type 2 diabetes
T49	disease_or_phenotypic_feature 2052 2059	obesity
T50	chemical 2072 2080	androgen
T51	chemical 2159 2170	fibronectin
T52	disease_or_phenotypic_feature 2210 2217	obesity
T53	disease_or_phenotypic_feature 2230 2237	obesity
T54	chemical 2246 2256	biomarkers
T55	chemical 2280 2294	mTOR inhibitor
T56	chemical 2296 2308	temsirolimus
T57	chemical 2361 2371	biomarkers
T58	disease_or_phenotypic_feature 2442 2454	malignancies
T59	chemical 2492 2501	Marizomib
T60	disease_or_phenotypic_feature 2530 2551	peripheral neuropathy
T61	chemical 2596 2617	proteasome inhibitors
T62	disease_or_phenotypic_feature 2670 2680	depression
T63	chemical 2848 2857	serotonin
T64	chemical 2862 2870	dopamine
T65	chemical 2897 2903	oxygen
T66	disease_or_phenotypic_feature 2963 2974	lung tumors
T67	chemical 3006 3012	oxygen
T68	disease_or_phenotypic_feature 3022 3032	lung tumor
T69	chemical 3126 3142	antigen-specific
T70	disease_or_phenotypic_feature 3263 3274	hyperplasia
T2	missed_chemical 255 264	Syrbactin
R2	treats Arg1:T10 Arg2:T11	
T72	missed_chemical 552 557	NEDD8
T73	missed_chemical 653 658	NEDD8
T74	missed_disease_or_phenotypic_feature 867 887	depressive disorders
T75	missed_disease_or_phenotypic_feature 889 935	pain related to diabetic peripheral neuropathy
T76	missed_chemical 1661 1668	miR-375
T39	missed_chemical 1839 1849	filgotinib
T41	missed_disease_or_phenotypic_feature 1879 1889	infections
T44	missed_disease_or_phenotypic_feature 1912 1924	malignancies
T77	missed_disease_or_phenotypic_feature 1926 1955	gastrointestinal perforations
T79	missed_disease_or_phenotypic_feature 2555 2575	hematologic toxicity
T80	missed_chemical 2644 2649	PAI-1
T81	missed_disease_or_phenotypic_feature 2979 2986	hypoxic
T83	DONE 3293 3297	DONE
T84	missed_disease_or_phenotypic_feature 948 968	urinary incontinence
T85	missed_chemical 200 207	hormone
T7	corrected_disease_or_phenotypic_feature 193 218	growth hormone deficiency
T86	missed_chemical 286 293	TIR-199
T87	corrected_chemical 255 285	Syrbactin proteasome inhibitor
R8	treats Arg1:T87 Arg2:T11	
T88	corrected_chemical 789 813	Duloxetine hydrochloride
R3	treats Arg1:T88 Arg2:T84	
T89	missed_disease_or_phenotypic_feature 2400 2418;2442 2454	epithelial ovarian malignancies
R6	causes_or_contributes_to Arg1:T61 Arg2:T79	
R7	causes_or_contributes_to Arg1:T61 Arg2:T60	
T90	corrected_disease_or_phenotypic_feature 2423 2454	primary peritoneal malignancies
R9	treats Arg1:T56 Arg2:T89	
R10	treats Arg1:T56 Arg2:T90	
T91	missed_chemical 3059 3078	Î”pep27 immunization
T92	missed_disease_or_phenotypic_feature 3111 3114	AAD
R11	treats Arg1:T91 Arg2:T92	
T93	corrected_disease_or_phenotypic_feature 3251 3275	goblet cell hyperplasia.
T94	missed_disease_or_phenotypic_feature 3212 3245	pulmonary eosinophil accumulation
T95	missed_disease_or_phenotypic_feature 3197 3207;3222 3245	peripheral eosinophil accumulation
R12	treats Arg1:T91 Arg2:T95	
R13	treats Arg1:T91 Arg2:T94	
R14	treats Arg1:T91 Arg2:T93	
R4	treats Arg1:T88 Arg2:T74	
R5	treats Arg1:T88 Arg2:T75	
R15	treats Arg1:T55 Arg2:T90	
R16	treats Arg1:T55 Arg2:T89	
R17	causes_or_contributes_to Arg1:T39 Arg2:T45	
R18	causes_or_contributes_to Arg1:T39 Arg2:T43	
T96	corrected_chemical 826 845	antidepressant drug
R19	treats Arg1:T96 Arg2:T74	
R20	treats Arg1:T96 Arg2:T75	
R21	treats Arg1:T96 Arg2:T84	
T97	corrected_chemical 789 799;815 818	Duloxetine HCl
R22	treats Arg1:T97 Arg2:T74	
R23	treats Arg1:T97 Arg2:T75	
R24	treats Arg1:T97 Arg2:T84	
R25	treats Arg1:T25 Arg2:T28	
R26	treats Arg1:T25 Arg2:T29	
R27	causes_or_contributes_to Arg1:T1 Arg2:T3	
T71	missed_disease_or_phenotypic_feature 2072 2091	androgen deficiency
R28	treats Arg1:T47 Arg2:T71	
R29	treats Arg1:T86 Arg2:T11	
